تفاعل #1111207

ord-389810643e9147619e3f9579727240b6

ظروف التفاعل

الظروف التفصيلية
See reaction.notes.procedure_details.

المعالجة

  1. 1
    أخرىwere reacted

الإجراء التجريبي

Following the procedures as described for compound 104b, 8-bromo-6-chloroimidazo[1,2-b]pyridazine 104a (233 mg, 1.0 mmol), and 5-(4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-amine (234 mg, 1.0 mmol) were reacted to give 105a as a white solid (296 mg, 77%). LCMS: [M+H]+ 386

المصدر

DOI: 10.6084/m9.figshare.5104873.v1براءة الاختراع: US08722676B2uspto-grants-2014_05